Skip to main content
Equibles

DIADEMA PARTNERS LP

Position in QURE — uniQure N.V.

CIK 2026172 MORRISTOWN, NJ
Back to QURE Full portfolio

Position in QURE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$510,120 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
7 quarters on record

Common Shares in QURE Over Time

Shares Held

Position Value (USD)

Derivatives in QURE

reported options exposure · as of Jun 30, 2026
CallValue
$10,842,524
CallShares
235,400
PutValue
$13,771,940
PutShares
299,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DIADEMA PARTNERS LP holds $217,374,297 across 66 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 139,218 $26,072,747
2 ABVX
Abivax S.A.
 163,644 $21,807,199
3 COGT
Cogent Biosciences, Inc.
 493,664 $19,104,796
4 BMRN
Biomarin Pharmaceutical Inc
 312,846 $17,901,048
5 VKTX
Viking Therapeutics, Inc.
 441,808 $17,234,930
6 EWTX
Edgewise Therapeutics, Inc.
 272,214 $11,060,054
7 KOD
Kodiak Sciences Inc.
 218,117 $8,497,838
8 IMCR
Immunocore Holdings plc
 254,863 $8,091,900

All Filings in QURE

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,771,940 299,000
2026-06-30 $10,842,524 235,400
2026-03-31 $4,888,650 299,000
2026-03-31 $4,087,500 250,000
2026-03-31 $510,120 31,200
2025-12-31 $7,222,074 301,800
2025-12-31 $1,076,850 45,000
2025-09-30 $17,511,000 300,000
2025-06-30 $1,451,154 104,100
2025-03-31 $1,633,460 154,100
2025-03-31 $386,900 36,500
2024-12-31 $1,766,000 100,000